to conduct a pharmacodynamic research into HBV recovery capsule prepared with Common Leafflower about its anti-HBV and protective effect of liver cells.Methods:anti- HBV effect was observed through in vitro experiment in 2.2.15 cell line. Rat model of chronic liver injury was established using CCl₄, and was divided to blank control group, CCl₄ group, Yigan Ning Group, and Leafflower high-dose group, middle-dose group and low-dose group. Each group was subject to biochemical examination and histological examination to pathological changes in left hepatic lobe; peritoneal macrophage phagocytosis and content of haemolysin were determined in mice to observe the capsule’s effect on immune function.Results:maximum inhibition ratio of HBsAg and HBeAg were respectively 76.47%(d7) and71.43%(d5), moreover, HBV secretion and replication correlated positively with inhibitive action. When compared with CCl₄ group, the leafflower group improved significantly in liver function, with less severe liver disorganization and fibroplasias; and was superior over various parameter value to Yigan Ning group. The leafflower group had similar effect as Levamisole, which was better than the blank control group: phagocytosis of peritoneal macrophage was reinforced, and content of haemolysin increased following sensitization induced by sheep red blood cell.Conclusion:HBV recovery capsule prepared with Common Leafflower had anti-HBV effect and protection of liver cells.